However, using BRAFV600E inhibitors alone could easily induce glioma cells’ resistance to them, the escape mechanisms of glioma cells included the up‐regulation of the Wnt pathway and increased activity of receptor tyrosine kinases, including EGFR.60 Here, NTRK1 is linked to central nervous system cancer.